loadpatents
name:-0.02994704246521
name:-0.01465892791748
name:-0.013463973999023
Gavathiotis; Evripidis Patent Filings

Gavathiotis; Evripidis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gavathiotis; Evripidis.The latest application filed is for "pyrazol-3-ones that activate pro-apoptotic bax".

Company Profile
13.16.28
  • Gavathiotis; Evripidis - Roslyn NY
  • Gavathiotis; Evripidis - Boston MA
  • Gavathiotis; Evripidis - Flushing NY
  • GAVATHIOTIS; Evripidis - Bronx NY
  • Gavathiotis; Evripidis - New York NY
  • Gavathiotis; Evripidis - Quincy MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrazol-3-ones That Activate Pro-apoptotic Bax
App 20220298154 - Walensky; Loren D. ;   et al.
2022-09-22
Compounds Useful For Inhibiting Raf Dimers
App 20220265669 - GAVATHIOTIS; Evripidis ;   et al.
2022-08-25
BAX activators and uses thereof in cancer therapy
Grant 11,382,898 - Gavathiotis , et al. July 12, 2
2022-07-12
Pyrazol-3-ones that activate pro-apoptotic BAX
Grant 11,358,960 - Walensky , et al. June 14, 2
2022-06-14
Benzoxazole And Related Compounds Useful As Chaperone-mediated Autophagy Modulators
App 20210387953 - Cuervo; Ana Maria ;   et al.
2021-12-16
Synthetic antibodies to BAX and uses thereof
Grant 11,174,308 - Gavathiotis , et al. November 16, 2
2021-11-16
Compounds Useful As Chaperone-mediated Autophagy Modulators
App 20210317095 - CUERVO; Ana Maria ;   et al.
2021-10-14
Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseases
Grant 11,098,021 - Cheng , et al. August 24, 2
2021-08-24
Retinoic Acid Receptor Antagonists As Chaperone-mediated Autophagy Modulators And Uses Thereof
App 20210053958 - CUERVO; Ana Maria ;   et al.
2021-02-25
Pyrazol-3-ones That Activate Pro-apoptotic Bax
App 20210032234 - Walensky; Loren D. ;   et al.
2021-02-04
Synthetic Antibodies To Bax And Uses Thereof
App 20200399356 - Gavathiotis; Evripidis ;   et al.
2020-12-24
Pyrazol-3-ones that activate pro-apoptotic BAX
Grant 10,844,053 - Walensky , et al. November 24, 2
2020-11-24
Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof
Grant 10,766,886 - Cuervo , et al. Sep
2020-09-08
Synthetic antibodies to BAX and uses thereof
Grant 10,759,851 - Gavathiotis , et al. Sep
2020-09-01
Mitofusin Activators And Uses Thereof
App 20200261469 - Gavathiotis; Evripidis ;   et al.
2020-08-20
Bax Activators And Uses Thereof In Cancer Therapy
App 20200093802 - Gavathiotis; Evripidis ;   et al.
2020-03-26
Small Molecule Bax Inhibitors And Uses Thereof
App 20200009132 - Gavathiotis; Evripidis ;   et al.
2020-01-09
Pyrazol-3-ones That Activate Pro-apoptotic Bax
App 20190315730 - Walensky; Loren D. ;   et al.
2019-10-17
Retinoic Acid Receptor Antagonists As Chaperone-mediated Autophagy Modulators And Uses Thereof
App 20190225599 - CUERVO; Ana Maria ;   et al.
2019-07-25
Pyrazol-3-ones that activate pro-apoptotic BAX
Grant 10,351,554 - Walensky , et al. July 16, 2
2019-07-16
Targeting Dimerization Of Bax To Modulate Bax Activity
App 20190202865 - Gavathiotis; Evripidis
2019-07-04
Synthetic Antibodies To Bax And Uses Thereof
App 20190161537 - Gavathiotis; Evripidis ;   et al.
2019-05-30
Synthetic antibodies to BAX and uses thereof
Grant 10,294,294 - Gavathiotis , et al.
2019-05-21
Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof
Grant 10,189,827 - Cuervo , et al. Ja
2019-01-29
Synthetic Antibodies To Bax And Uses Thereof
App 20180251532 - Gavathiotis; Evripidis ;   et al.
2018-09-06
Pyrazol-3-ones That Activate Pro-apoptotic Bax
App 20180244664 - Walensky; Loren D. ;   et al.
2018-08-30
Phenylsulfonamido-benzofuran Derivatives And Uses Thereof In The Treatment Of Proliferative Diseases
App 20180237407 - Cheng; Emily H. ;   et al.
2018-08-23
Pyrazol-3-ones that activate pro-apoptotic BAX
Grant 10,000,478 - Walensky , et al. June 19, 2
2018-06-19
Retinoic Acid Receptor Antagonists As Chaperone-mediated Autophagy Modulators And Uses Thereof
App 20180141937 - Cuervo; Ana Maria ;   et al.
2018-05-24
Retinoic acid receptor antagonists as chaperone-mediated authophagy modulators and uses thereof
Grant 9,890,143 - Cuervo , et al. February 13, 2
2018-02-13
Targeting Dimerization Of Bax To Modulate Bax Activity
App 20170114100 - Gavathiotis; Evripidis
2017-04-27
Retinoic Acid Receptor Antagonists As Chaperone-mediated Authophagy Modulators And Uses Thereof
App 20170037039 - Cuervo; Ana Maria ;   et al.
2017-02-09
Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof
Grant 9,512,092 - Cuervo , et al. December 6, 2
2016-12-06
Pyrazol-3-ones That Activate Pro-apoptotic BAX
App 20160264564 - Walensky; Loren D. ;   et al.
2016-09-15
Chemical Modulators of Pro-Apoptotic BAX and BCL-2 Polypeptides
App 20160171150 - Walensky; Loren D. ;   et al.
2016-06-16
Pyrazol-3-ones that activate pro-apoptotic BAX
Grant 9,303,024 - Walensky , et al. April 5, 2
2016-04-05
Small-molecule Binding Site On Pro-apoptotic Bax Regulates Inhibition Of Bax Activity
App 20150335671 - Gavathiotis; Evripidis ;   et al.
2015-11-26
Retinoic Acid Receptor Antagonists As Chaperone-mediated Autophagy Modulators And Uses Thereof
App 20150166492 - CUERVO; ANA MARIA ;   et al.
2015-06-18
Methods and compositions for modulating BCL-2 family polypeptides
Grant 8,921,323 - Walensky , et al. December 30, 2
2014-12-30
Pyrazol-3-ones That Activate Pro-apoptotic BAX
App 20140357687 - Walensky; Loren D. ;   et al.
2014-12-04
Chemical Modulators Of Pro-apoptotic Bax And Bcl-2 Polypeptides
App 20110218155 - Walensky; Loren D. ;   et al.
2011-09-08
Methods And Compositions For Modulating Bcl-2 Family Polypeptides
App 20100286057 - Walensky; Loren D. ;   et al.
2010-11-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed